What is the appropriate management of silicone breast implant rupture or leakage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Management of Silicone Breast Implant Rupture or Leakage

For symptomatic patients with suspected silicone breast implant rupture, MRI without IV contrast is the gold standard diagnostic imaging modality recommended by the FDA, followed by surgical explantation with thorough removal of leaked silicone and the fibrous capsule. 1

Diagnostic Approach

Symptomatic Patients

MRI without IV contrast is the FDA-recommended imaging study for evaluating suspected implant rupture in symptomatic patients 1. MRI demonstrates:

  • Sensitivity of 96% and specificity of 77% in symptomatic patients 1
  • Superior detection of intracapsular ruptures (most common type), which are invisible on mammography and difficult to diagnose by ultrasound
  • Classic signs include the "linguini sign" (wavy-line appearance) for complete intracapsular rupture—the most specific finding 1

Ultrasound can serve as an adjunct when MRI is unavailable or contraindicated 1:

  • Excellent for detecting extracapsular silicone with the classic "snowstorm" pattern
  • Recent data shows 94.7% diagnostic accuracy when performed by experts 1
  • If ≥2 signs of rupture are present on ultrasound, proceed with surgical management; if only 1 sign is present, confirm with MRI 1

Mammography/DBT identifies only extracapsular rupture (high-density silicone outside implant contour) but misses intracapsular ruptures entirely 1

Asymptomatic Patients

For asymptomatic screening, the FDA recommends first imaging at 5-6 years post-implantation, then every 2-3 years thereafter using either ultrasound or MRI 1. However, the benefit of routine screening remains controversial, particularly in patients >75 years old where observation may be more appropriate 2.

Surgical Management

Confirmed Rupture

Surgical explantation is the definitive treatment for confirmed implant rupture, particularly when symptomatic or when extracapsular leakage is present 1.

Key surgical principles:

  1. Complete silicone removal is critical to prevent capsular contracture recurrence:

    • Pulse lavage irrigation of the prosthetic pocket effectively removes leaked silicone and reduces histologic silicone remnants 3
    • Hydrosurgical debridement systems can be used for thorough silicone removal from capsular surfaces 4
    • Residual silicone in breast capsules significantly increases capsular contracture risk 3, 5

  2. Capsule management:

    • Open capsulotomy combined with pulse lavage is effective for concurrent capsular contracture (Baker III/IV) and rupture 3
    • This approach shows no significant difference in contracture recurrence rates (27.6% vs 22.2%) compared to intact implant exchanges when thorough silicone removal is performed 3
    • Complete capsulectomy may be considered in cases of extensive silicone contamination

  3. Implant replacement considerations:

    • Highly cohesive silicone implants demonstrate significantly lower silicone leakage rates than low-cohesive implants 6
    • For low-cohesive implants, consider exchange at 10-15 years post-implantation even without rupture to minimize silicone leakage 6
    • Younger patients with recurrent contracture should consider conversion to autologous tissue reconstruction 3

Special Populations

Patients >75 years with asymptomatic rupture:

  • Observation is reasonable unless symptoms develop 2
  • Discontinue routine surveillance imaging after age 75 2
  • Use shared decision-making incorporating comprehensive geriatric assessment for surgical candidates 2

Critical Pitfalls to Avoid

  • Do not rely on clinical examination alone—it is unreliable for diagnosing rupture 1
  • Do not use mammography alone for symptomatic patients—it misses intracapsular ruptures entirely 1
  • Do not perform incomplete silicone removal—even small amounts (0.26 mL) increase capsular contracture risk by 12% 5
  • In patients with prior silicone implants, high-density material on imaging may represent residual silicone rather than new rupture—comparison with prior studies is essential 1
  • Iatrogenic damage is the most common cause of rupture—exercise extreme care during surgical manipulation 7

Evidence Quality Note

The 2023 ACR Appropriateness Criteria [1-1] represent the highest quality, most recent guideline evidence and form the foundation of these recommendations. The FDA recommendations embedded within these guidelines carry regulatory authority and should guide clinical decision-making.

References

1
Guideline

acr appropriateness criteria® breast implant evaluation: 2023 update.

Journal of the American College of Radiology, 2023

Related Questions

In a patient with suture dehiscence and no possibility of re‑suturing, who has postoperative tension on a silicone implant, what is the appropriate management and what laser therapy protocol should be used for tissue regeneration and wound healing?
What is the appropriate ICD‑10‑CM diagnostic code for a breast implant complication identified on MRI?
What is the emergency department management for a patient with a ruptured saline breast implant?
How to diagnose a suspected ruptured breast implant in a patient after a fall?
What are the implications of a ruptured breast implant (prosthetic device)?
In a long-term-care resident with a new non-productive cough but no fever or chills, should I empirically order a chest radiograph?
What does vaginal bleeding at 7 weeks gestation indicate?
What is the clinical significance and recommended management of internal frontal bone hyperostosis, a small residual encephalocele with marginal gliosis in the left parietal lobe, and supratentorial gliosis due to chronic microangiopathic disease?
Is it appropriate to begin therapy with Humulin R (regular insulin) in a patient with HbA1c 10.3% and rising serum potassium, and what initial dose should be given to correct the hyperglycaemia?
Which baseline laboratory tests should I order and how should I interpret the results for a 59‑year‑old male presenting for a routine exam with intermittent non‑sharp chest discomfort, mild shortness of breath, recent nausea with tachycardia, unilateral knee pain, and a brief episode of fatigue?
What alternative lipid‑lowering medication can be given to a patient who develops joint pain while taking atorvastatin?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.